Find a Doctor

Home » Doctors » Hyderabad » Dr. Hima Bindu Avatapalle

Brief Profile

Dr Hima Bindu worked as

Worked as Consultant Paediatric , Adolescent  at Leads Teaching Hospitals.

1) Done Mphil( University of Manchester for Research in Congenital Hyper insulinism ).  2) Been awarded the 2009 Sir Peter Tizard Bursary from British Paediatric Surveillance unit to undertake a 13 month study to identify important aspects of autoimmune Addison’s disease in the paediatric population in the UK.  3) Best CME Case presentation in BSPED

Educational Qualification

  • MBBS
  • DCH
  • CCT (Paediatric Endocrinology
  • Diabetes and General Paediatrics)
  • MPhil (University Of Manchester)
  • Honorary Senior Lecturer
  • Leeds University

Treatment & Services Expertise

Paediatric endocrinology clinics (Type 1 and Type 2 Diabetes in children, rarer forms of childhood diabetes, growth, puberty, thyroid, adrenals, genital abnormalities (Disorders of sexual development (DSD), gender Identity, neonatal and childhood hypoglycaemia , Endocrine late effects of Childhood Cancer Specialist Obesity,  adolescent endocrine disorders &  Metabolic Bone Disease

Trainings and conferences

1) Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism. Indraneel Banerjee, Lynette Forsythe, Mars Skae, Hima Bindu Avatapalle, Lindsey Rigby, Louise E. Bowden, Ross Craigie, Raja Padidela, Sarah Ehtisham, Leena Patel, Karen E. Cosgrove, Mark J. Dunne,and Peter E. Clayton. Frontiers in Endocrinology. 2016; 7: 8.

2) Reduced glycaemic variability in diazoxide-responsive children with congenital hyperinsulinism using supplemental omega-3-polyunsaturated fatty acids; a pilot trial with MaxEPAR . M Skae, H B Avatapalle, I Banerjee, L Rigby, A Vail, P Foster, C Charalambous, L Bowden, R Padidela, L Patel, S Ehtisham, K E Cosgrove, M J Dunne, P E Clayton. Frontiers in Endocrinology  2014; 5: 31.

3) Abnormal Neurodevelopmental Outcomes are Common in Children with transient Congenital Hyperinsulinism. Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, Caine L, Didi M, Skae M, Ehtisham S, Patel L, Padidela R, Cosgrove KE, Dunne MJ, Clayton PE. Front Endocrinol (Lausanne). 2013 May 20;4:60.

4)Increased plasma incretin concentrations identifies a subset of patients with persistent congenital hyperinsulinism without KATP channel gene defects. Shi Y, Avatapalle HB, Skae MS, Padidela R, Newbould M, Rigby L, Flanagan SE, Ellard S, Rahier J, Clayton PE, Dunne MJ, Banerjee I, Cosgrove KE. J Pediatr. 2015 Jan;166(1):191-4.

5)Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. Banerjee I, Avatapalle B, Padidela R, Stevens A, Cosgrove KE, Clayton PE, Dunne MJ. ClinEndocrinol (Oxf). 2013 Jun;78(6):803-13.

6)The association of cardiac ventricular hypertrophy with congenital hyperinsulinism. Banerjee I, Avatapalle B, Petkar A, Skae M, Padidela R, Ehtisham S, Patel L, Rigby L, Flanagan S, Ellard S, Jones C, Ciotti G, Malaiya N, Clayton PE. Eur J Endocrinol. 2012 Nov;167(5):619-24.

7)Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism. Avatapalle B, Padidela R, Randell T, Banerjee I. BMJ Case Rep. 2012 Jul 30;2012   

8)Echocardiography monitoring for diazoxide induced pericardial effusion. Avatapalle B, Banerjee I, Malaiya N, Padidela R. BMJ Case Rep. 2012 Jul 3;2012.

Professional Membership

1) Royal College of Paediatrics and Child Health 

2) British Society of Paediatric Endocrinology and Diabetes (BSPED )

3) European Society of Paediatric Endocrinology

Book an Appointment